<DOC>
	<DOCNO>NCT01725035</DOCNO>
	<brief_summary>Nonalcoholic Fatty Liver Disease ( NAFLD ) become common cause liver disease pediatrics , little known pathophysiology child . While study obese adult hepatic steatosis describe increased hepatic de novo lipogenesis ( DNL ) depend diet , study explore mechanisms excess hepatic triglyceride increase obese youth , thus explain accompany dyslipidemia metabolic syndrome . The central hypothesis study hepatic conversion carbohydrate lipid ( DNL ) enhance associate accumulation excess liver fat , dyslipidemia hepatic insulin resistance obese youth hepatic steatosis . The overall goal examine whether hepatic DNL increase obese youth steatosis compare match control without steatosis . Hypotheses : Hepatic conversion carbohydrate lipid ( DNL ) enhance associate accumulation excess liver fat , dyslipidemia hepatic insulin resistance obese youth hepatic steatosis .</brief_summary>
	<brief_title>Hepatic De Novo Lipogenesis ( DNL ) Pathogenesis Hepatic Steatosis Obese Youth</brief_title>
	<detailed_description>In study obese youth ( 12-18 year ) undergo MRI ( magnetic resonance imaging ) measurement liver lipid content determine hepatic fat content . They undergo sugary drink ( 75 gram glucose 25 gram fructose ) challenge Hepatic de novo lipogenesis determine incorporation deuterium , deuterium label water ( D2O ) , plasma triglyceride . Subjects undergo 6 hour study assess de novo lipogenesis , oral glucose tolerance test , dual energy x-ray absorptiometry , magnetic resonance imaging , Euglycemic-Hyperinsulinemic Clamp .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<criteria>Cases meet follow criterion : Age 12 18 year BMI high 85th percentile Hepatic fat fraction ( amount fat liver ) great equal 5.5 % Absence endocrinopathy Absence therapy medication know alter glucose metabolism Controls meet follow criterion : Age 12 18 year BMI high 85th percentile Hepatic fat fraction ( amount fat liver ) low 5.5 % Absence endocrinopathy Absence therapy medication know alter glucose metabolism BMI 85th percentile Hepatic fat fraction ( amount fat liver ) less 5.5 % Absence endocrinopathy Any therapy medication know alter glucose metabolism Controls meet follow criterion : BMI 85th percentile Hepatic fat fraction ( amount fat liver ) great equal 5.5 % Any endocrinopathy Any therapy medication know alter glucose metabolism</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>De Novo Lipogenesis</keyword>
	<keyword>Fatty Liver</keyword>
	<keyword>Hepatic Steatosis</keyword>
	<keyword>Gene variant</keyword>
</DOC>